
Opinion|Videos|September 20, 2024
Current Advancements in Biomarker Research
The panel explores promising biomarker research that has the potential to significantly impact patient care in prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What current advancements in biomarker research are you most excited about? (Brian Richardson, MD)
- Lysine-specific demethylase-1
- Appl1, Sortilin, and Syndecan-1
- Please highlight any others.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5

















